Shield Therapeutics PLC
F:1JS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR per share.
Compared with the current market price of 0.037 EUR, the stock appears
Undervalued by 49% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Shield Therapeutics Does
Shield Therapeutics is a specialty pharmaceutical company focused on treating iron deficiency and iron deficiency anaemia. Its main product is an oral iron medicine designed for patients who cannot tolerate standard iron pills or who need a different way to replace iron. The company sells prescription medicine to healthcare providers and pharmacies, so the real customers are doctors, hospitals, and patients using the treatment under medical supervision.
- Headquarters
- United Kingdom UK
- Employees
- 63
- IPO date
- Feb 26, 2016
Continue 1JS Research
Decided on Shield Therapeutics? Get an email when 1JS reaches the price you’d buy at. Free with an account.
Other Shield Therapeutics listings
What is the Intrinsic Value of one 1JS stock?
The intrinsic value for
Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR.
Is 1JS stock undervalued or overvalued?
Compared with the current market price of 0.037 EUR, the stock appears Undervalued by 49% .